DREAMM-6: Safety, Tolerability and Clinical Activity of Belantamab Mafodotin (Belamaf) in Combination with Bortezomib/Dexamethasone (BorDex) in Relapsed/Refractory Multiple Myeloma (RRMM)
暂无分享，去创建一个
A. Nooka | A. Khot | Deborah A. Smith | M. Mateos | R. Abonour | B. Kremer | R. M. D. Oca | G. Ferron-Brady | Bikramjit Chopra | A. Spencer | R. Popat | K. Stockerl-Goldstein | A. Yeakey | H. Quach | I. Gupta | B. Augustson | Cindy H. Lee | M. Talekar | Rachel Rogers | A. Forbes | R. Ramaekers | J. Davidge | B. Chopra | R. Rogers | Rocio Montes de Oca | Geraldine Ferron-Brady